株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

ティッシュエンジニアリング (組織工学):技術および治療領域 - 世界市場の概要

Tissue Engineering: Technologies and Therapeutic Areas - A Global Market Overview

発行 Industry Experts 商品コード 231701
出版日 ページ情報 英文 374 Pages, 145 Charts
即納可能
価格
本日の銀行送金レート: 1USD=109.55円で換算しております。
Back to Top
ティッシュエンジニアリング (組織工学):技術および治療領域 - 世界市場の概要 Tissue Engineering: Technologies and Therapeutic Areas - A Global Market Overview
出版日: 2019年06月24日 ページ情報: 英文 374 Pages, 145 Charts
概要

世界のティッシュエンジニアリング市場規模は、2019年に254億米ドルへ達すると予測されています。用途別では整形外科、筋骨格 & 脊椎用途が世界市場で最大のシェアを構成しており、2018年に135億米ドル (60.5%) と推計され、2024年までに347億米ドルに達する見込みです。

当レポートでは、世界のティッシュエンジニアリング市場について調査し、マテリアルタイプ・用途別の分析と予測を提供しており、主要地域・国別の分析、近年の市場動向、製品・事業動向、および主要企業などをまとめています。

第1章 イントロダクション

  • 製品アウトライン
    • ティッシュエンジニアリングのイントロダクション
    • ティッシュエンジニアリングで使用されるマテリアル
    • ティッシュエンジニアリングの用途

第2章 主な市場動向

第3章 主な世界的企業

  • Acell Inc. (米国)
  • Allergan Plc (アイルランド)
  • Athersys, Inc. (米国)
  • B. Braun Melsungen AG (ドイツ)
  • Biotime, Inc. (米国)
  • Biotissue SA (スイス)
  • C. R. Bard, Inc. (米国)
  • Cryolife Inc. (米国)
  • Integra Lifesciences Holdings Corporation (米国)
  • International Stem Cell Corporation (米国)
  • Medtronic, Inc. (米国)
  • Organogenesis Inc. (米国)
  • Osiris Therapeutics, Inc. (米国)
  • Reprocell Inc. (日本)
  • RTI Surgical (米国)
  • Stryker Corporation (米国)
  • Tissue Regenix Ltd (英国)
  • Vericel Corporation (米国)
  • Wright Medical Group (英国)
  • Zimmer Biomet (米国)

第4章 主な事業動向・製品動向

第5章 世界市場の概要

  • 世界のティッシュエンジニアリング市場概要:マテリアルタイプ別
    • 世界の組織エンジニアリング技術概要:地域別
      • バイオミメティックマテリアル
      • コンポジットマテリアル
      • ナノコンポジットマテリアル
      • ナノファイバーマテリアル
  • 世界のティッシュエンジニアリング市場概要:用途別
    • 世界の組織エンジニアリング用途概要:地域別
      • 心臓 & 血管
      • 歯科/口腔
      • 神経科
      • 整形外科、筋骨格 & 脊椎
      • 皮膚/外皮
      • その他

パートB:地域市場の見通し

地域市場の概要

第6章 北米

  • 北米のティッシュエンジニアリング市場概要:地域別
  • 北米のティッシュエンジニアリング市場概要:マテリアルタイプ別
  • 北米のティッシュエンジニアリング市場概要:用途別
  • 主要企業
  • 北米のティッシュエンジニアリング市場概要:国別

第7章 欧州

第8章 アジア太平洋

第9章 その他 (ROW)

パートC:産業ガイド

  • 北米
  • 欧州
  • アジア太平洋
  • その他

パートD

目次
Product Code: BT009

Report Synopsis

Organs developed using Tissue Engineering are highly durable and efficient, with applications gaining ground in areas, such as surgical manipulation of tissues and prosthetics for cardiac, cancer and orthopedic uses. The technology has reached a stage where the products offer a reduced rate of rejection by the body, which would further propel the market for Tissue Engineering. Though North America is the leading global region for revenues garnered from Tissue Engineering, Asia-Pacific is likely to outpace all other regions by posting the fastest CAGR over the analysis period.

Orthopedics, Musculoskeletal & Spine applications corner the largest share of the global market for Tissue Engineering in terms of application, which is estimated at 60.5% or US$13.5 billion in 2018 and is projected to reach US$34.7 billion by 2024 at a CAGR of 17.1% between the two years. Overall, Tissue Engineering market, globally, for 2019 is projected to touch US$25.4 billion.

image1

Research Findings & Coverage

  • The global market for Tissue Engineering analyzed in this report with respect to Material Types and Applications
  • The study explores the afore mentioned categories of Tissue Engineering in each major region/country worldwide for the analysis period
  • Biomaterials for Tissue Engineering Get Innovative
  • Successful Creation of Functioning Kidney Tissue by Researchers
  • Human Trials of Novel Tissue-Engineered Blood Vessel Replacements Now Closer
  • Plasma Protein Shows Promise for Making Wound-Healing Tissue Scaffolds
  • Key business trends focusing on product innovations/developments, M&As, JVs and other recent industry developments
  • Major companies profiled - 38
  • The industry guide includes the contact details for 270 companies

Product Outline

The report analyzes the market for the following material types of Tissue Engineering including:

  • Biomimetic Materials
  • Composite Materials
  • Nanocomposite Materials
  • Nanofibrous Materials

The market for applications of Tissue Engineering explored in this report includes:

  • Cancer
  • Cardiology & Vascular
  • Dental/Oral
  • Neurology
  • Orthopedics, Musculoskeletal & Spine
  • Skin/Integumentary
  • Others

Analysis Period, Units and Growth Rates

  • The report reviews, analyzes and projects the global Tissue Engineering market for the period 2015-2024 in terms of US$ and the compound annual growth rates (CAGRs) projected from 2018 through 2024

Geographic Coverage

  • North America (The United States, Canada and Mexico)
  • Europe (France, Germany, Italy, The United Kingdom and Rest of Europe)
  • Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific)
  • South America (Argentina, Brazil and Rest of SA)
  • Rest of World

Table of Contents

PART A: GLOBAL MARKET PERSPECTIVE

1. INTRODUCTION

  • 1.1 Product Outline
    • 1.1.1 An Introduction to Tissue Engineering
      • 1.1.1.1 Clinical Need for Tissue Engineering and Regenerative Medicine
      • 1.1.1.2 Basics of Tissue Engineering and Regenerative Medicine
        • 1.1.1.2.1 Tissue Engineering versus Regenerative Medicine
        • 1.1.1.2.2 The Three Pillars of Tissue Engineering
    • 1.1.2 Materials Used In Tissue Engineering
      • 1.1.2.1 Biomimetic Materials
        • 1.1.2.1.1 Biomimetic Biodegradability
        • 1.1.2.1.2 Mechanical Properties of Biomimetic Materials
      • 1.1.2.2 Nanofibrous Materials
        • 1.1.2.2.1 Electrospinning
        • 1.1.2.2.2 Self-Assembly
        • 1.1.2.2.3 Phase Separation
        • 1.1.2.2.4 Nanofibrous Architecture and its Biological Effects
      • 1.1.2.3 Composite and Nanocomposite Materials
      • 1.1.2.4 Modification of Surfaces
      • 1.1.2.5 Bioactive Molecule Delivery
    • 1.1.3 Applications of Tissue Engineering
      • 1.1.3.1 Cancer Applications
        • 1.1.3.1.1 Cancer Biology from Tissue Engineering's Perspective
        • 1.1.3.1.2 Tissue Engineering Technology Platforms' Translation into Cancer Research
      • 1.1.3.2 Cardiology & Vascular Applications
        • 1.1.3.2.1 Cardiac Tissue Engineering: An Overview
        • 1.1.3.2.2 Identification of Basic Cell Responses
          • 1.1.3.2.2.1 Materials and Degradation
          • 1.1.3.2.2.2 Attachment
          • 1.1.3.2.2.3 Stiffness
          • 1.1.3.2.2.4 Diffusion and Porosity
          • 1.1.3.2.2.5 Forces
        • 1.1.3.2.3 3-Dimensional Tissue Engineering
        • 1.1.3.2.4 Further 3-D Approaches and Considerations
        • 1.1.3.2.5 Cardiovascular Tissue Engineering and Bioreactor Technology
        • 1.1.3.2.6 Limiting Cells or Materials
      • 1.1.3.3 Dental/Oral Applications
        • 1.1.3.3.1 Dental Tissue Regeneration through Tissue Engineering Strategy
        • 1.1.3.3.2 Harvesting Teeth Created by Tissue Engineering
        • 1.1.3.3.3 Research Goals Currently Targeted
        • 1.1.3.3.4 Process of Tissue Engineering for Tooth Replacement: What Future Trends Indicate
      • 1.1.3.4 Neurology Applications
        • 1.1.3.4.1 Neural Tissue Engineering or Neuroregeneration
        • 1.1.3.4.2 Biomaterial Scaffold Development for Nerve Tissue Engineering: Biomaterial Mediated Neural Regeneration
          • 1.1.3.4.2.1 Response to Injury and Repair
          • 1.1.3.4.2.2 Neural Cells' Regeneration Potential
          • 1.1.3.4.2.3 Regeneration Promoted through Growth Factor Delivery
          • 1.1.3.4.2.4 Biomaterials in Nerve Regeneration
          • 1.1.3.4.2.5 Polymeric Scaffolds as Extracellular Matrix Analogues
          • 1.1.3.4.2.6 Geometric Indicators: Structure of Scaffolds
          • 1.1.3.4.2.7 Nanofiber Properties and Electrospinning Technology
          • 1.1.3.4.2.8 Alternate Approaches
          • 1.1.3.4.2.9 Electrical Cues
      • 1.1.3.5 Orthopedics, Musculoskeletal & Spine Applications
        • 1.1.3.5.1 Bone Regeneration Using Orthopedic Tissue Engineering
        • 1.1.3.5.2 Articular Cartilage Degeneration and Osteoarthritis, Repair, Regeneration and Transplantation
          • 1.1.3.5.2.1 Cartilage Repair
          • 1.1.3.5.2.2 Osteochondral Allograft Transplantation
      • 1.1.3.6 Skin/Integumentary Applications
        • 1.1.3.6.1 Burns
        • 1.1.3.6.2 Diabetic Ulcers
        • 1.1.3.6.3 Venous Ulcers
        • 1.1.3.6.4 Plastic and Reconstructive Surgery
      • 1.1.3.7 Other Applications
        • 1.1.3.7.1 Autoimmune Disorders
        • 1.1.3.7.2 Ophthalmology
        • 1.1.3.7.3 Organ Replacement/Transplant
          • 1.1.3.7.3.1 Categories of Transplant
          • 1.1.3.7.3.2 Major Organs and Tissues Transplanted
        • 1.1.3.7.4 Urology
          • 1.1.3.7.4.1 Conditions Affecting the Urological System
            • 1.1.3.7.4.1.1 The Kidney
            • 1.1.3.7.4.1.2 The Ureter
            • 1.1.3.7.4.1.3 The Urinary Bladder
            • 1.1.3.7.4.1.4 The Urinary Sphincters
            • 1.1.3.7.4.1.5 The Urethra
          • 1.1.3.7.4.2 Stem Cells Offering Promise in Urological Regenerative Medicine
          • 1.1.3.7.4.3 Polymeric Materials and their Potential Applications in Urologic Regenerative Medicine
      • 1.1.3.8 In Conclusion

2. KEY MARKET TRENDS

  • 2.1 Latest Developments in Tissue Engineering
    • Advances in Cell Sourcing and Manipulation
    • Advances in Biomaterials and Scaffold Production
    • Advances in Cell Signaling Research and Bioreactor Development
  • 2.2 Biomaterials for Tissue Engineering Get Innovative
  • 2.3 First Successful Lung Stem Cell Transplantation Clinical Trial Reported
  • 2.4 Successful Creation of Functioning Kidney Tissue by Researchers
  • 2.5 Human Trials of Novel Tissue-Engineered Blood Vessel Replacements Now Closer
  • 2.6 Plasma Protein Shows Promise for Making Wound-Healing Tissue Scaffolds
  • 2.7 Speed of Bone Repair Process May be Accelerated with the Help of Two Types of Cells
  • 2.8 New Therapy Developed for Osteomyelitis
  • 2.9 Treatment of Critical-Sized Bone Defects with New Biomaterial-Based Autograft Extender on the Cards
  • 2.10 Development of New method of Repairing Early Stage Vaginal Prolapses Targeted
  • 2.11 Self-Curving Cornea Created Using Innovative Biological System
  • 2.12 Patients with Cartilage Defects Get the Boon of Cartilage Tissue Engineering
  • 2.13 Minute Biodegradable Scaffold Help in Transplanting Stem Cells and Delivering Drugs

3. KEY GLOBAL PLAYERS

  • Acell Inc. (United States)
  • Allergan Plc (Ireland)
  • Athersys, Inc. (United States)
  • B. Braun Melsungen AG (Germany)
  • Biotime, Inc. (United States)
  • Biotissue SA (Switzerland)
  • C. R. Bard, Inc. (United States)
  • Cryolife Inc. (United States)
  • Integra Lifesciences Holdings Corporation (United States)
  • International Stem Cell Corporation (United States)
  • Medtronic, Inc. (United States)
  • Organogenesis Inc. (United States)
  • Osiris Therapeutics, Inc. (United States)
  • Reprocell Inc. (Japan)
  • RTI Surgical® (United States)
  • Stryker Corporation (United States)
  • Tissue Regenix Ltd (United Kingdom)
  • Vericel Corporation (United States)
  • Wright Medical Group (United Kingdom)
  • Zimmer Biomet (United States)

4. KEY BUSINESS AND PRODUCT TRENDS

  • Organogenesis Bags Innovative Wound Care and Surgical Contract from Vizient, Inc
  • Apax Funds, CPPIB and PSP Investments Agree to Sell Acelity and its KCI Subsidiaries to 3M
  • Royal DSM and SAT Join Hands to Develop Transcatheter Replacement Heart Valves
  • Medtronic Plc to Acquire Titan Spine, Inc
  • Smith & Nephew Plc Acquires Osiris Therapeutics, Inc
  • ACell, Inc Selects First Horizon, LLC and Weihai Jierui Medical Products Co., Ltd as Distributor
  • FDA Clearance for ACell's Gentrix® Surgical Matrix suite of products
  • Isto Biologics Develops New Cortical Fiber Technology
  • Integra LifeSciences Receives Approval of DuraGen Regeneration Substitute
  • FDA Approval for Zimmer Biomet's ROSA® ONE Spine System
  • Zimmer Biomet Showcases its Latest Personalized Medical Technological Innovations at AAOS 2019, Nevada
  • Wright Medical Showcases REVIVE™ Revision Shoulder System at AAOS 2019, Nevada
  • Stryker Corporation Acquires OrthoSpace, Ltd
  • RTI Surgical Holdings, Inc Acquires Paradigm Spine
  • Organogenesis Holdings, Inc Reveals PuraPly® Antimicrobial Impacts on Wound Healing
  • ACell, Inc. Selects MyungMoon as Distributor in South Korea
  • Cerapedics, Inc Reveals ISASS Bone Grafting Policy Statement Featuring i-FACTOR™ Peptide Enhanced Bone Graft
  • Japan Tissue Engineering Co., Ltd Files Application for Manufacturing and Marketing Cultured Autologous Corneal Epithelium in Japan
  • KCI Unveils ABTHERA™ Abdomen Therapy in Japan
  • Stryker Corporation Acquires Arrinex, Inc
  • Medtronic Plc Announce Japan's First Grafton(TM) Demineralized Bone Matrix (DBM) Bone Grafting Product for Spine and Orthopedic Application
  • Cook Medical, Inc Acquires Whitaker Park's Facility to Produce Life-Saving Medical Devices
  • Vericel Corporation and Innovative Cellular Therapeutics Co., Ltd. Join Forces on Advanced Cell Therapy Portfolio
  • DePuy Synthes Unveils New Femoral Neck Implant System
  • International Stem Cell Corporation Receives United States Patent and Trademark Office for Lysate Stem Cell
  • KCI Forms Agreement with Highmark Inc to Promote its iOn PROGRESS™ Remote Therapy Monitoring Program
  • U.S. Stem Cell, Inc Expands Regenerative Therapies Business Entity
  • Cytori Therapeutics, Inc Expands Class III Medical Device Portfolio in Japan
  • Stryker Corporation Acquires K2M
  • RTI Surgical, Inc and HealthPartners Announce Minimally Invasive Sacroiliac Joint Fusion Surgery Development
  • CE Mark Approval for Medtronic's Valiant Navion (TM) Thoracic Stent Graft System
  • Wright Medical Acquires Cartiva, Inc.
  • Stryker Corporation Buys HyperBranch Medical
  • FDA Clearance for Allergan Plc's CoolSculpting® Treatment
  • Hesperos, Inc Bags three-year NIH Phase IIB Small Business Innovation Research (SBIR) Grant from National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS)
  • DePuy Synthes Launches New Digital Mechanomyography Platform - SENTIO MMG
  • RTI Surgical, Inc Showcases its Next-Generation Spine Implant Technologies at NASS 2018, Los Angeles
  • Osiris Therapeutics, Inc Unveils New GrafixPL PRIME™ Human Placental
  • Baxter Receives FDA Approval for ACTIFUSE Bone Graft Substitute and ALTAPORE Bioactive Bone Graft Substitute
  • Johnson & Johnson Medical GmbH Acquires Emerging Implant Technologies GmbH
  • Integra LifeSciences Receives Contract from Healogics® Inc for Cellular-Based Tissue Products
  • Hesperos, Inc to Develop Multi-Organ "human-on-a-chip" Model for Alzheimer's Therapies
  • RTI Surgical, Inc and Aziyo Biologics, Inc Agree to Distribute ViBone® Matrix Product for Spine and Other Orthopedic Procedures
  • LEITR and RTIDS Announce Strategic Collaboration on Tissue Donation
  • AgeX Therapeutics Inc Acquires UniverCyte technology Patent from Escape Therapeutics Inc
  • International Stem Cell Corporation Developed 3D Liver Structures
  • Cerapedics, Inc Conducts Investigational Device Exemption (IDE) Clinical Trials of P-15L Peptide Enhanced Bone Graft
  • Wright Medical Displays its Innovations at AOFAS 2018 at the Hynes Convention Center in Boston, Massachusetts
  • Athersys Inc Registers First Patient in Masters-2 Phase 3 Study of Multistem® Treatment for Ischemic Stroke
  • DePuy Synthes Introduces CONCORDE LIFT Expandable Interbody Implant for Spine Surgery Use
  • The Organisation for Economic Co-operation and Development (OECD) integrates "LabCyte CORNEA-MODEL24", an eye Irritancy Testing Method
  • Japan Tissue Engineering Co., Ltd. Submits Clinical Trial of Autologous Cultured Epidermis with Melanocyte to PMDA
  • DePuy Synthes Develops New Femoral Recon Nail System
  • Osiris Therapeutics, Inc Employs Prestige Lyotechnology? Preservation Method
  • GoLiver Therapeutics Obtains Pluripotent Cell Technology License from BioTime Inc
  • DePuy Synthes Launches DYNACORD Suture to Repair Soft Tissue
  • Japan Tissue Engineering, Nagoya University, and Shinshu University Agree Enter an Agreement on Autologous CAR-T Cell Therapy Technology Development
  • Cerapedics, Inc Reveals i-FACTOR IVANOS Study Results
  • FDA Approval for Zimmer Biomet's Zyston® Strut Open Titanium Interbody Spacer System
  • Organogenesis Showcased Apligraf Treatment Option at International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2018 in Baltimore, U.S
  • ACell, Inc Reaches Milestones for Gentrix® Surgical Matrix Portfolio
  • DePuy Synthes Unveils GLOBAL UNITE Reverse Fracture Shoulder Implant Solution
  • DePuy Synthes and Prosidyan Join Hands to Promote FIBERGRAFT® Family of Products for Spine Fusion Surgery
  • International Stem Cell Corporation Receives Patent - US9926529B2 to Produce ISC-hpNSC Cells
  • Zimmer Biomet Receives FDA Clearance for Persona® Trabecular Metal™ Tibia Knee Solution
  • U.S. Stem Cell, Inc Establishes New Clinic in Central Florida
  • Organogenesis Showcases PuraPly® Antimicrobial Treatment at SAWC Spring 2018, North Carolina
  • UTHealth and Athersys, Inc Agree on MultiStem® Cell Therapy Study for Trauma Injury Use
  • DePuy Synthes Introduce PROTI 360° Family of Implants for Spinal Fusion Surgery Use
  • FDA Approval for Medtronic's Infuse(TM) Bone Graft
  • FDA Approval for Cerapedics' IDE to Study P-15L Bone Graft for Transforaminal Lumbar Interbody Fusion Surgery
  • Zimmer Biomet Showcases Technological Innovations at AAOS 2018
  • Wright Medical Highlights Invision™ Prophecy Total Ankle Revision System at ACFAS 2018 in Nashville, Tennessee
  • Aziyo Biologics Inc and Cook Biotech Inc Unite to Develop Bio-Envelope Solution
  • Cook Biotech Inc and Regentys Corporation Collaborate on Developing Ulcerative Colitis Treatment
  • ATT Selects ACell as Distributor of Wound Care Products
  • Astellas Buys Universal Cells, Inc.
  • RTI Surgical, Inc Acquires Zyga Technology, Inc.
  • AgeX Therapeutics, Inc Study Reveals Genes Implicated In Tissue Regeneration and Cancer
  • CryoLife, Inc Acquires JOTEC AG
  • ACell, Inc Launches Dynamic Tissue Systems® (DTS) Product Portfolio
  • FUJIFILM Sign an Agreement with Cyfuse Biomedical K.K. to Produce Regenerative Medicine Products
  • Athersys, Inc and Nikon CeLL innovation Co., Ltd Enter into Agreement on MultiStem® Stem Cell Therapy Production in Japan
  • DSM Biomedical and Cerapedics, Inc Collaborate on Peptide Enhanced Bone Graft
  • Integra LifeSciences Unveils Revize™/ Revize™-X Collagen Matrix Tissue-Building for Plastic and Reconstructive Surgery
  • International Stem Cell Corporation Obtains Stem Cell Patent in Australia
  • International Stem Cell Corporation Concludes the Traumatic Brain Injury (TBI) Phase II Clinical Trial
  • FUJIFILM Corporation and NC Medical Research, Inc Join Hands on Regenerative Medicine Portfolio
  • RTI Surgical, Inc Sells its Cardiothoracic Closure Business to A&E Advanced Closure Systems, LLC
  • Medtronic Plc Receives CE mark and U.S FDA approval for its Avalus (TM) Pericardial Aortic Surgical Valve
  • Vericel Highlights MACI Implant for Treating Articular Cartilage Defects in the Knee at AOSSM 2017 Meeting
  • Medtronic Plc Launches CoreValve(TM) Evolut(TM) PRO Transcatheter Valve for Heart Surgery
  • BioTime, Inc Expands its Ophthalmology Business
  • Isto Biologics Acquires Progenicare LLC
  • Vericel Receives FDA RMAT Designation for Ixmyelocel-T Used in Advanced Heart Failure
  • Integra LifeSciences Introduces SurgiMend® MP Collagen Tissue-Building Matrix for Hernia Repair
  • RTI Surgical, Inc Expands its Tissue Market
  • DePuy Synthes Acquires 3D Printing Technologies to Treat Bone Defects from Tissue Regeneration Systems, Inc
  • U.S. Stem Cell, Inc and Advanced Stem Cell Rx Form an Alliance to Commercialize Cell Therapies
  • Organogenesis, Inc Acquires NuTech Medical, Inc
  • DePuy Synthes Mitek Sports Medicine Launches Knee Arthroscopy Platform
  • Ethicon, Inc and DePuy Synthes Develop Wound Closure Kits for Orthopaedic Surgery Application
  • FDA Approval for Medtronic's Melody Transcatheter Pulmonary Valve (TPV) for Surgical Pulmonary Heart Valves
  • Allergan Plc Acquires LifeCell Corporation
  • DePuy Synthes Develops New ViviGen Formable™ Cellular Bone Matrix
  • ACell, Inc Join Forces with Southmedic Inc
  • BioTime, Inc Along with its Subsidiary Cell Cure Neurosciences Ltd Establish Cell Therapy Center in Center in Jerusalem, Israel
  • Cytori Therapeutics, Inc Intensify on ECCS-50 formulation Investigation of Cytori Cell Therapy® to Include Secondary Raynaud's Phenomenon (RP)
  • Cytori Therapeutics, Inc Acquires Azaya Therapeutics Inc

5. GLOBAL MARKET OVERVIEW

  • 5.1 Global Tissue Engineering Market Overview by Material Type
    • 5.1.1 Tissue Engineering Material Type Market Overview by Global Region
      • 5.1.1.1 Biomimetic Materials
      • 5.1.1.2 Composite Materials
      • 5.1.1.3 Nanocomposite Materials
      • 5.1.1.4 Nanofibrous Materials
  • 5.2 Global Tissue Engineering Market Overview by Application
    • 5.2.1 Tissue Engineering Application Market Overview by Global Region
      • 5.2.1.1 Cancer Applications
      • 5.2.1.2 Cardiology & Vascular Applications
      • 5.2.1.3 Dental/Oral Applications
      • 5.2.1.4 Neurology Applications
      • 5.2.1.5 Orthopedics, Musculoskeletal & Spine Applications
      • 5.2.1.6 Skin/Integumentary Applications
      • 5.2.1.7 Other Applications

PART B: REGIONAL MARKET PERSPECTIVE

REGIONAL MARKET OVERVIEW

6. NORTH AMERICA

  • 6.1 North American Tissue Engineering Market Overview by Geographic Region
  • 6.2 North American Tissue Engineering Market Overview by Material Type
  • 6.3 North American Tissue Engineering Market Overview by Application
  • 6.4 Major Market Players
    • Acelity L.P. Inc. (United States)
    • Acell Inc. (United States)
    • Astellas Institute for Regenerative Medicine (United States)
    • Athersys, Inc. (United States)
    • Baxter International Inc. (United States)
    • Biocomposites Inc. (United States)
    • Biotime, Inc. (United States)
    • C. R. Bard, Inc. (United States)
    • Cerapedics, Inc. (United States)
    • Cook Biotech, Inc. (United States)
    • Cook Medical LLC (United States)
    • Cryolife Inc. (United States)
    • Cytori Therapeutics, Inc. (United States)
    • Depuy Synthes (United States)
    • DSM Biomedical (United States)
    • Integra Lifesciences Holdings Corporation (United States)
    • International Stem Cell Corporation (United States)
    • ISTO Biologics (United States)
    • Medtronic, Inc. (United States)
    • Nuo Therapeutics, Inc. (United States)
    • Organogenesis Inc. (United States)
    • Osiris Therapeutics, Inc. (United States)
    • RTI Surgical® (United States)
    • Sanofi Genzyme (United States)
    • Stryker Corporation (United States)
    • U.S. Stem Cell, Inc. (United States)
    • Vericel Corporation (United States)
    • Zimmer Biomet (United States)
  • 6.5 Country-wise Analysis of North American Tissue Engineering Market
    • 6.5.1 The United States
      • 6.5.1.1 United States Tissue Engineering Market Overview by Material Type
      • 6.5.1.2 United States Tissue Engineering Market Overview by Application
    • 6.5.2 Canada
      • 6.5.2.1 Canadian Tissue Engineering Market Overview by Material Type
      • 6.5.2.2 Canadian Tissue Engineering Market Overview by Application
    • 6.5.3 Mexico
      • 6.5.3.1 Mexican Tissue Engineering Market Overview by Material Type
      • 6.5.3.2 Mexican Tissue Engineering Market Overview by Application

7. EUROPE

  • 7.1 European Tissue Engineering Market Overview by Geographic Region
  • 7.2 European Tissue Engineering Market Overview by Material Type
  • 7.3 European Tissue Engineering Market Overview by Application
  • 7.4 Major Market Players
    • Allergan Plc (Ireland)
    • B. Braun Melsungen AG (Germany)
    • TETEC® Tissue Engineering Technologies AG (Germany)
    • Biotissue SA (Switzerland)
    • Episkin (France)
    • Tissue Regenix Ltd (United Kingdom)
    • Wright Medical Group (United Kingdom)
  • 7.5 Country-wise Analysis of European Tissue Engineering Market
    • 7.5.1 France
      • 7.5.1.1 French Tissue Engineering Market Overview by Material Type
      • 7.5.1.2 French Tissue Engineering Market Overview by Application
    • 7.5.2 Germany
      • 7.5.2.1 German Tissue Engineering Market Overview by Material Type
      • 7.5.2.2 German Tissue Engineering Market Overview by Application
    • 7.5.3 Italy
      • 7.5.3.1 Italian Tissue Engineering Market Overview by Material Type
      • 7.5.3.2 Italian Tissue Engineering Market Overview by Application
    • 7.5.4 The United Kingdom
      • 7.5.4.1 United Kingdom Tissue Engineering Market Overview by Material Type
      • 7.5.4.2 United Kingdom Tissue Engineering Market Overview by Application
    • 7.5.5 Rest of Europe
      • 7.5.5.1 Rest of Europe Tissue Engineering Market Overview by Material Type
      • 7.5.5.2 Rest of Europe Tissue Engineering Market Overview by Application

8. ASIA-PACIFIC

  • 8.1 Asia-Pacific Tissue Engineering Market Overview by Geographic Region
  • 8.2 Asia-Pacific Tissue Engineering Market Overview by Material Type
  • 8.3 Asia-Pacific Tissue Engineering Market Overview by Application
  • 8.4 Major Market Players
    • Japan Tissue Engineering Co., Ltd. (Japan)
    • Mesoblast Ltd (Australia)
    • Reprocell Inc. (Japan)
  • 8.5 Country-wise Analysis of Asia-Pacific Tissue Engineering Market
    • 8.5.1 China
      • 8.5.1.1 Chinese Tissue Engineering Market Overview by Material Type
      • 8.5.1.2 Chinese Tissue Engineering Market Overview by Application
    • 8.5.2 India
      • 8.5.2.1 Indian Tissue Engineering Market Overview by Material Type
      • 8.5.2.2 Indian Tissue Engineering Market Overview by Application
    • 8.5.3 Japan
      • 8.5.3.1 Japanese Tissue Engineering Market Overview by Material Type
      • 8.5.3.2 Japanese Tissue Engineering Market Overview by Application
    • 8.5.4 South Korea
      • 8.5.4.1 South Korean Tissue Engineering Market Overview by Material Type
      • 8.5.4.2 South Korean Tissue Engineering Market Overview by Application
    • 8.5.5 Rest of Asia-Pacific
      • 8.5.5.1 Rest of Asia-Pacific Tissue Engineering Market Overview by Material Type
      • 8.5.5.2 Rest of Asia-Pacific Tissue Engineering Market Overview by Application

9. SOUTH AMERICA

  • 9.1 South American Tissue Engineering Market Overview by Geographic Region
  • 9.2 South American Tissue Engineering Market Overview by Material Type
  • 9.3 South American Tissue Engineering Market Overview by Application
  • 9.4 Country-wise Analysis of South American Tissue Engineering Market
    • 9.4.1 Argentina
      • 9.4.1.1 Argentine Tissue Engineering Market Overview by Material Type
      • 9.4.1.2 Argentine Tissue Engineering Market Overview by Application
    • 9.4.2 Brazil
      • 9.4.2.1 Brazilian Tissue Engineering Market Overview by Material Type
      • 9.4.2.2 Brazilian Tissue Engineering Market Overview by Application
    • 9.4.3 Rest of South America
      • 9.4.3.1 Rest of South America Tissue Engineering Market Overview by Material Type
      • 9.4.3.2 Rest of South America Tissue Engineering Market Overview by Application

10. REST OF WORLD

  • 10.1 Rest of World Tissue Engineering Market Overview by Material Type
  • 10.2 Rest of World Tissue Engineering Market Overview by Application

PART C: GUIDE TO THE INDUSTRY

  • 1. NORTH AMERICA
  • 2. EUROPE
  • 3. ASIA-PACIFIC
  • 4. REST OF WORLD

PART D: ANNEXURE

  • 1. RESEARCH METHODOLOGY
  • 2. FEEDBACK

Charts & Graphs

PART A: GLOBAL MARKET PERSPECTIVE

  • Chart 1: Global Tissue Engineering Market (2018 & 2024) by Material Type
  • Chart 2: Global Tissue Engineering Market (2018 & 2024) by Application
  • Chart 3: Global Tissue Engineering Market (2018 & 2024) by Geographic Region
  • Chart 4: Global Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 5: Global Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 6: Glance at 2015, 2018 and 2024 Global Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 7: Global Tissue Engineering Market Analysis (2015-2024) for Biomimetic Materials by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 8: Glance at 2015, 2018 and 2024 Global Tissue Engineering Market Share (%) for Biomimetic Materials by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 9: Global Tissue Engineering Market Analysis (2015-2024) for Composite Materials by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 10: Glance at 2015, 2018 and 2024 Global Tissue Engineering Market Share (%) for Composite Materials by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 11: Global Tissue Engineering Market Analysis (2015-2024) for Nanocomposite Materials by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 12: Glance at 2015, 2018 and 2024 Global Tissue Engineering Market Share (%) for Nanocomposite Materials by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 13: Global Tissue Engineering Market Analysis (2015-2024) for Nanofibrous Materials by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 14: Glance at 2015, 2018 and 2024 Global Tissue Engineering Market Share (%) for Nanofibrous Materials by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 15: Global Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 16: Glance at 2015, 2018 and 2024 Global Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications
  • Chart 17: Global Tissue Engineering Market Analysis (2015-2024) for Cancer Applications by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 18: Glance at 2015, 2018 and 2024 Global Tissue Engineering Market Share (%) for Cancer Applications by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 19: Global Tissue Engineering Market Analysis (2015-2024) for Cardiology & Vascular Applications by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 20: Glance at 2015, 2018 and 2024 Global Tissue Engineering Market Share (%) for Cardiology & Vascular Applications by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 21: Global Tissue Engineering Market Analysis (2015-2024) for Dental/Oral Applications by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 22: Glance at 2015, 2018 and 2024 Global Tissue Engineering Market Share (%) for Dental/Oral Applications by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 23: Global Tissue Engineering Market Analysis (2015-2024) for Neurology Applications by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 24: Glance at 2015, 2018 and 2024 Global Tissue Engineering Market Share (%) for Neurology Applications by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 25: Global Tissue Engineering Market Analysis (2015-2024) for Orthopedics, Musculoskeletal & Spine Applications by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 26: Glance at 2015, 2018 and 2024 Global Tissue Engineering Market Share (%) for Orthopedics, Musculoskeletal & Spine Applications by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 27: Global Tissue Engineering Market Analysis (2015-2024) for Skin/Integumentary Applications by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 28: Glance at 2015, 2018 and 2024 Global Tissue Engineering Market Share (%) for Skin/Integumentary Applications by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World
  • Chart 29: Global Tissue Engineering Market Analysis (2015-2024) for Other Applications by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 30: Glance at 2015, 2018 and 2024 Global Tissue Engineering Market Share (%) for Other Applications by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World

PART B: REGIONAL MARKET PERSPECTIVE

  • Chart 31: Global Tissue Engineering Market Analysis (2015-2024) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World in USD Million
  • Chart 32: Glance at 2015, 2018 and 2024 Global Tissue Engineering Market Share (%) by Geographic Region - North America, Europe, Asia-Pacific, South America and Rest of World

REGIONAL MARKET OVERVIEW

NORTH AMERICA

  • Chart 33: North American Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 34: North American Tissue Engineering Market Analysis (2015-2024) by Geographic Region - United States, Canada and Mexico in USD Million
  • Chart 35: Glance at 2015, 2018 and 2024 North American Tissue Engineering Market Share (%) by Geographic Region - United States, Canada and Mexico
  • Chart 36: North American Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 37: Glance at 2015, 2018 and 2024 North American Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 38: North American Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 39: Glance at 2015, 2018 and 2024 North American Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

The United States

  • Chart 40: United States Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 41: United States Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 42: Glance at 2015, 2018 and 2024 United States Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 43: United States Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 44: Glance at 2015, 2018 and 2024 United States Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

Canada

  • Chart 45: Canadian Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 46: Canadian Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 47: Glance at 2015, 2018 and 2024 Canadian Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 48: Canadian Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 49: Glance at 2015, 2018 and 2024 Canadian Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

Mexico

  • Chart 50: Mexican Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 51: Mexican Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 52: Glance at 2015, 2018 and 2024 Mexican Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 53: Mexican Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 54: Glance at 2015, 2018 and 2024 Mexican Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

EUROPE

  • Chart 55: European Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 56: European Tissue Engineering Market Analysis (2015-2024) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe in USD Million
  • Chart 57: Glance at 2015, 2018 and 2024 European Tissue Engineering Market Share (%) by Geographic Region - France, Germany, Italy, United Kingdom and Rest of Europe
  • Chart 58: European Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 59: Glance at 2015, 2018 and 2024 European Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 60: European Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 61: Glance at 2015, 2018 and 2024 European Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

France

  • Chart 62: French Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 63: French Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 64: Glance at 2015, 2018 and 2024 French Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 65: French Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 66: Glance at 2015, 2018 and 2024 French Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

Germany

  • Chart 67: German Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 68: German Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 69: Glance at 2015, 2018 and 2024 German Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 70: German Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 71: Glance at 2015, 2018 and 2024 German Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

Italy

  • Chart 72: Italian Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 73: Italian Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 74: Glance at 2015, 2018 and 2024 Italian Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 75: Italian Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 76: Glance at 2015, 2018 and 2024 Italian Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

The United Kingdom

  • Chart 77: United Kingdom Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 78: United Kingdom Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 79: Glance at 2015, 2018 and 2024 United Kingdom Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 80: United Kingdom Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 81: Glance at 2015, 2018 and 2024 United Kingdom Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

Rest of Europe

  • Chart 82: Rest of Europe Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 83: Rest of Europe Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 84: Glance at 2015, 2018 and 2024 Rest of Europe Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 85: Rest of Europe Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 86: Glance at 2015, 2018 and 2024 Rest of Europe Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

ASIA-PACIFIC

  • Chart 87: Asia-Pacific Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 88: Asia-Pacific Tissue Engineering Market Analysis (2015-2024) by Geographic Region - China, India, Japan, South Korea and Rest of Asia-Pacific in USD Million
  • Chart 89: Glance at 2015, 2018 and 2024 Asia-Pacific Tissue Engineering Market Share (%) by Geographic Region - China, India, Japan, South Korea and Rest of Asia-Pacific
  • Chart 90: Asia-Pacific Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 91: Glance at 2015, 2018 and 2024 Asia-Pacific Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 92: Asia-Pacific Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 93: Glance at 2015, 2018 and 2024 Asia-Pacific Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

China

  • Chart 94: Chinese Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 95: Chinese Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 96: Glance at 2015, 2018 and 2024 Chinese Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 97: Chinese Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 98: Glance at 2015, 2018 and 2024 Chinese Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

India

  • Chart 99: Indian Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 100: Indian Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 101: Glance at 2015, 2018 and 2024 Indian Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 102: Indian Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 103: Glance at 2015, 2018 and 2024 Indian Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

Japan

  • Chart 104: Japanese Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 105: Japanese Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 106: Glance at 2015, 2018 and 2024 Japanese Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 107: Japanese Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 108: Glance at 2015, 2018 and 2024 Japanese Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

South Korea

  • Chart 109: South Korean Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 110: South Korean Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 111: Glance at 2015, 2018 and 2024 South Korean Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 112: South Korean Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 113: Glance at 2015, 2018 and 2024 South Korean Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

Rest of Asia-Pacific

  • Chart 114: Rest of Asia-Pacific Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 115: Rest of Asia-Pacific Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 116: Glance at 2015, 2018 and 2024 Rest of Asia-Pacific Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 117: Rest of Asia-Pacific Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 118: Glance at 2015, 2018 and 2024 Rest of Asia-Pacific Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

SOUTH AMERICA

  • Chart 119: South American Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 120: South American Tissue Engineering Market Analysis (2015-2024) by Geographic Region - Argentina, Brazil and Rest of South America in USD Million
  • Chart 121: Glance at 2015, 2018 and 2024 South American Tissue Engineering Market Share (%) by Geographic Region - Argentina, Brazil and Rest of South America
  • Chart 122: South American Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 123: Glance at 2015, 2018 and 2024 South American Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 124: South American Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 125: Glance at 2015, 2018 and 2024 South American Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

Argentina

  • Chart 126: Argentine Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 127: Argentine Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 128: Glance at 2015, 2018 and 2024 Argentine Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 129: Argentine Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 130: Glance at 2015, 2018 and 2024 Argentine Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

Brazil

  • Chart 131: Brazilian Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 132: Brazilian Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 133: Glance at 2015, 2018 and 2024 Brazilian Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 134: Brazilian Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 135: Glance at 2015, 2018 and 2024 Brazilian Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

Rest of South America

  • Chart 136: Rest of South American Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 137: Rest of South American Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 138: Glance at 2015, 2018 and 2024 Rest of South American Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 139: Rest of South American Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 140: Glance at 2015, 2018 and 2024 Rest of South American Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications

REST OF WORLD

  • Chart 141: Rest of World Tissue Engineering Market Analysis (2015-2024) in USD Million
  • Chart 142: Rest of World Tissue Engineering Market Analysis (2015-2024) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials in USD Million
  • Chart 143: Glance at 2015, 2018 and 2024 Rest of World Tissue Engineering Market Share (%) by Material Type - Biomimetic Materials, Composite Materials, Nanocomposite Materials and Nanofibrous Materials
  • Chart 144: Rest of World Tissue Engineering Market Analysis (2015-2024) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications in USD Million
  • Chart 145: Glance at 2015, 2018 and 2024 Rest of World Tissue Engineering Market Share (%) by Application - Cancer, Cardiology & Vascular, Dental/Oral, Neurology, Orthopedics, Musculoskeletal & Spine, Skin/Integumentary and Other Applications
Back to Top